← Leaderboards
Amanda Simcox
Ohio State University
$3,429,625
Attributed
$4,774,790
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $717.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,774,790 · 6
By mechanism
R24$2,690,330 · 1
R01$1,337,485 · 1
R21$410,225 · 1
R03$315,000 · 2
F06$21,750 · 1
Top collaborators
- Norbert Perrimon5 shared
Most similar at Ohio State University
Same institution · by research overlap
- Piotr Rychahou$324,149
- Manisha Shah$775,581
Others in their field
Top investigators on “Drosophila Genus”
- Norbert Perrimon · Harvard Medical School$77,620,742
- Hugo J Bellen · Baylor College Of Medicine$32,341,526
- Susan E Celniker · University Of Calif-Lawrenc Berkeley Lab$32,260,987
- Craig Montell · University Of California Santa Barbara$30,891,067
- William Martin Gelbart · Harvard University$30,745,494
- Claude Desplan · New York University$23,033,750
Research focus
Drosophila GenusCellsGenesBiologicalCell LineSiteSignal TransductionCell TypeGeneticCommunitiesCultured CellsResearch PersonnelBiochemistryBaseHuman DiseaseTissuesPathway InteractionsMutantReagentTumor Suppressor GenesBackGene Expression ProfileClustered Regularly Interspaced Short Palindromic RepeatsCell Lineage
Grant awards (16)
Linking systemic and local signaling for proportional growth$157,500
R03 · FY2025 · HD · contact PI
Killing dormant tumor cells: the role of autopagy$78,750
R03 · FY2023 · CA · contact PI
Killing dormant tumor cells: the role of autopagy$78,750
R03 · FY2022 · CA · contact PI
Next-generation Drosophila cell lines to elucidate the cellular basis of human diseases$645,802
R24 · FY2020 · OD
Next-generation Drosophila cell lines to elucidate the cellular basis of human diseases$655,302
R24 · FY2019 · OD
Next-generation Drosophila cell lines to elucidate the cellular basis of human diseases$62,632
R24 · FY2019 · OD
Next-generation Drosophila cell lines to elucidate the cellular basis of human diseases$655,302
R24 · FY2018 · OD
Next-generation Drosophila cell lines to elucidate the cellular basis of human diseases$671,292
R24 · FY2017 · OD
Genetically tractable in vitro systems for Drosophila$219,600
R21 · FY2011 · HD · contact PI
Genetically tractable in vitro systems for Drosophila$190,625
R21 · FY2010 · HD · contact PI
Development of tissue-specific cell lines in Drosophila$139,005
R01 · FY2009 · GM · contact PI
Development of tissue-specific cell lines in Drosophila$283,506
R01 · FY2007 · GM · contact PI
Development of tissue-specific cell lines in Drosophila$291,974
R01 · FY2006 · GM · contact PI
Development of tissue-specific cell lines in Drosophila$299,000
R01 · FY2005 · GM
Development of tissue-specific cell lines in Drosophila$324,000
R01 · FY2004 · GM
Analysis of EGF receptor signaling using DNA microarrays$21,750
F06 · FY2001 · TW